As of Oct 17
| +1.19 / +1.89%|
The 13 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 55.00, with a high estimate of 72.00 and a low estimate of 43.00. The median estimate represents a -14.17% decrease from the last price of 64.08.
The current consensus among 16 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.